====== Monika Naus ======

{{ ::ctn_monika-naus.jpeg?150|}}

Dr. **Monika Naus** is a Canadian epidemiologist based in [[canada:british_columbia:Vancouver]], [[canada:British Columbia]]. She currently serves as Medical Director of the Communicable Diseases & Immunization Service at the [[BC Centre for Disease Control]] (BCCDC).
===== Education =====

Naus obtained her medical training at the [[University of Alberta]] and her training in Public Health and Preventive Medicine at the [[University of Toronto]].

She is a Fellow of the [[Royal College of Physicians of Canada]] and of the [[American College of Preventive Medicine]].  

===== Affiliations =====

Naus is active on the [[Canadian Immunization Committee]], [[Canadian Immunization Registries and Coverage Network]], [[Automated Identification of Vaccine Products Working Group]], [[Canadian Immunization Research Network]] and other national and provincial committees. She is a member of the [[Manufacturing Safety Alliance of British Columbia]].((//Dr. Monika Naus.// Manufacturing Safety Alliance of BC. Retrieved April 20, 2022, from https://safetyalliancebc.ca/people/dr-monika-naus/))
==== Health Canada ====

Naus served as a federal field epidemiologist with the [[Laboratory Centre for Disease Control]] prior to starting her career in [[public health]], with a focus on communicable disease prevention and control.

==== Public Health Agency of Canada ====

=== National Advisory Committee on Immunization ===

Naus is a liaison representative for the [[Canadian Immunization Committee]] on the [[National Advisory Committee on Immunization]] (NACI), where she was responsible for initially approving the [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html)) She previously served as Chair from 2003-2007 after being a member for eight years, and is a member of several NACI expert groups.

==== Ontario Ministry of Health and Long Term Care ====

Naus was the provincial epidemiologist in Ontario from 1997 to 2001, and a senior medical consultant in vaccine preventable diseases and TB control for the [[Ontario Ministry of Health and Long-Term Care]] from 1990 to 1997. 

==== BC Centre for Disease Control ====

Naus is the Medical Director of the Communicable Diseases & Immunization Service at [[BC Centre for Disease Control]] (BCCDC).((//Monika Naus.// BC Centre for Disease Control. Retrieved April 21, 2022, from http://www.bccdc.ca/our-research/people/monika-naus)) She began at the BCCDC in July 2001.

==== University of British Columbia ====

Naus is a professor in the [[University of British Columbia]] (UBC) School of Population & Public Health.((//Monika Naus.// BC Centre for Disease Control. Retrieved April 21, 2022, from http://www.bccdc.ca/our-research/people/monika-naus))

==== STRIVEBC ====

Naus is a member of the [[STRIVEBC]] (Sexually Transmitted Infections Vaccine) Consortium.((//Consortium Members.// STRIVEBC. Retrieved April 20, 2022, from https://archive.ph/EXe9G)) The consortium is partnered with several [[World Health Organization]]-affiliated organizations, and those funded by the [[National Institutes of Health]] (NIH).((//Affiliate Organizations.// STRIVEBC. Retrieved April 20, 2022, from https://archive.ph/rYkGh))

===== Research =====

Naus was part of a study funded by the [[Center for Disease Control and Prevention|Centres for Disease Control and Prevention]] studying [[H1N1]] vaccines.((Weibel, D., Sturkenboom, M., Black, S., de Ridder, M., Dodd, C., Bonhoeffer, J., Vanrolleghem, A., van der Maas, N., Lammers, G. J., Overeem, S., Gentile, A., Giglio, N., Castellano, V., Kwong, J. C., Murray, B. J., Cauch-Dudek, K., Juhasz, D., Campitelli, M., Datta, A. N., & Kallweit, U. (2018). //Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment.// Vaccine, 36(41), 6202–6211. https://doi.org/10.1016/j.vaccine.2018.08.008)) 

She has also received funding from the [[Michael Smith Foundation for Health Research]] and the [[Canadian Immunization Research Network]] (CIRN).((Donken, R., Dobson, S. R. M., Marty, K. D., Cook, D., Sauvageau, C., Gilca, V., Dionne, M., McNeil, S., Krajden, M., Money, D., Kellner, J., Scheifele, D. W., Kollmann, T., Bettinger, J. A., Liu, S., Singer, J., Naus, M., Sadarangani, M., & Ogilvie, G. S. (2019). //Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.// Clinical Infectious Diseases, 71(4), 1022–1029. https://doi.org/10.1093/cid/ciz887))

===== Media =====

==== Presentations ====

On August 20, 2020, Naus presented at a workshop titled "The Critical Public Health Value of Vaccines – Tackling Issues of Access and Hesitancy" alongside [[Peter Daszak]], Chair of the [[Forum on Microbial Threats]] and President of [[EcoHealth Alliance]].((//The Critical Public Health Value of Vaccines - Tackling Issues of Access and Hesitancy - A Workshop.// (2022). National Academies of Sciences, Engineering and Medicine. https://archive.ph/hl2cR)) 

The event was sponsored by [[Biomedical Advanced Research and Development Authority]] (BARDA), [[EcoHealth Alliance]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Sanofi]], [[United States Agency for International Development]] (USAID), [[center for disease control and prevention|United States Centers for Disease Control and Prevention]] (CDC), US [[Department of Homeland Security]], US [[Department of Veterans Affairs]], US [[Food and Drug Administration]] (FDA), US [[National Institutes of Health]], [[Uniformed Services University of the Health Sciences]], [[American Society of Tropical Medicine and Hygiene]], and [[Infectious Diseases Society of America]].((NASEM Health and Medicine Division. (2020, August 28). //Welcome Remarks.// YouTube. https://www.youtube.com/watch?v=rjWp9_Tx87M))

In her presentation, Naus referenced the notion of putting vaccines in the water supply, and said, "we are learning to communicate in the right way, based not just on facts, but to appeal to feelings and emotions and to work with media."((Peter Daszak [@PeterDaszak]. (2020, August 20). //..“But we are learning to communicate in the right way, based not just on facts, but to appeal to feelings and emotions and to work with media”. [Tweet].// Twitter. https://archive.ph/uWoOY)) ((NASEM Health and Medicine Division. (2020, August 28). //Visionary Statements on Priorities in Building Vaccine Acceptance and Uptake for the Next Generation.// YouTube. https://web.archive.org/web/20220421053409/https://www.youtube.com/watch?v=TpVnU6zBdU8))

[[EcoHealth Alliance]] is affiliated with the [[Bill & Melinda Gates Foundation]],((//EcoHealth Alliance Inc.// (2020, August). Bill & Melinda Gates Foundation. https://archive.ph/69rNG)) as is USAID.((Gates, B. (2012). //Foreign Assistance, innovation, and Progress.// Frontiers in Development, 170–180. USAID. https://web.archive.org/web/20220421055443/https://www.usaid.gov/sites/default/files/documents/1868/BillGates.pdf))

===== External links =====

  * [[https://covidtruthinitiative.ca/en/Individuals/Monika-Naus|COVID Truth Initiative]]